Abstract | UNLABELLED: New drugs are urgently needed for improved therapy for melanoma. MATERIALS AND METHODS: Ninety-one novel compounds were evaluated in two melanoma and one normal skin cell lines to identify potential lead compounds with high potency and selectivity. Mechanisms of action for the best compound were also investigated. RESULTS: CONCLUSION: The lead structure represents a novel class of compounds that can be further optimized for potential drug to treat advanced melanoma.
|
Authors | Wei Li, Zhao Wang, Veeresa Gududuru, Blazej Zbytek, Andrzej T Slominski, James T Dalton, Duane D Miller |
Journal | Anticancer research
(Anticancer Res)
2007 Mar-Apr
Vol. 27
Issue 2
Pg. 883-8
ISSN: 0250-7005 [Print] Greece |
PMID | 17465215
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amides
- Antineoplastic Agents
- Benzenesulfonates
- Phenylurea Compounds
- Pyridines
- Thiazolidines
- Niacinamide
- Sorafenib
|
Topics |
- Amides
(chemistry, pharmacology)
- Antineoplastic Agents
(chemistry, pharmacology)
- Benzenesulfonates
(pharmacology)
- Cell Death
(drug effects)
- Cell Growth Processes
(drug effects)
- Cell Line, Tumor
- Humans
- Inhibitory Concentration 50
- Melanoma
(drug therapy, pathology)
- Necrosis
- Niacinamide
(analogs & derivatives)
- Phenylurea Compounds
- Pyridines
(pharmacology)
- Sorafenib
- Structure-Activity Relationship
- Thiazolidines
(chemistry, pharmacology)
|